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S U M M A R Y
Objective: To describe the recalled medical history, clinical manifestations, and treatment of yaws and
syphilis by syphilis seroreactive blood donors in Kumasi, Ghana.
Methods: Of the blood donors at Komfo Anokye Teaching Hospital, Kumasi, Ghana tested with the
syphilis rapid diagnostic test (RDT) and later by rapid plasma reagin (RPR) test, 526 were seroreactive.
Four hundred and seventy-one (89.5%) of these subjects were conﬁrmed with the Ortho-Vitros Syphilis
TP test as the gold standard and were interviewed to determine past or present clinical manifestations of
yaws and syphilis.
Results: Of the 471 respondent donors, 28 (5.9%) gave a history of skin lesions and sores; four (14.3%) of
these subjects, who were all male and RPR-positive, recalled a diagnosis of syphilis. All four reported
having had skin lesions/bumps with slow-healing sores, but only one of them had had these symptoms
before the age of 15 years.
Conclusions: A small proportion of conﬁrmed seroreactive donors in this sample had any recall of
symptoms or treatment for yaws or syphilis. These data suggest that clinical questioning adds little
further information to the current screening algorithm. The relative contribution of yaws and syphilis to
frequent positive tests in endemic areas remains speculative.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Yaws is a neglected non-venereal endemic treponematosis
caused by the bacterium Treponema pallidum subspecies pertenue.1
It is spread by direct skin-to-skin contact and predominantly
affects children less than 15 years of age living in poor socio-
economic conditions in certain rural, wet, and tropical areas.2 In
Ghana, a total of 28 000 cases were reported in 2008 and 25 000 in
2010. In 2012, the World Health Organization (WHO) launched a
new initiative to eradicate yaws globally by 2020 using the Morges
strategy.3 The clinical manifestations of yaws include multiple
papillomas, non-tender ulcers, sores, plantar hyperkeratosis, and* Corresponding author at: Francis Sarkodie Komfo Anokye Teaching Hospital,
Transfusion Medicine Unit Kumasi, Ghana. Tel.: +233244371770.
E-mail address: fsarkodie29@gmail.com (F. Sarkodie).
http://dx.doi.org/10.1016/j.ijid.2016.08.006
1201-9712/ 2016 The Author(s). Published by Elsevier Ltd on behalf of International S
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).pigmentation of the palms and soles, followed by gummata in the
last stage.1
Syphilis is a sexually transmitted disease caused by Treponema
pallidum subspecies pallidum. It can also be transmitted via blood
transfusion, although the actual risk is low.4 Syphilis starts with a
primary lesion (chancre – usually on the genitals), followed by a
polymorphic rash and lymphadenopathy. This is followed by the
occurrence of a generalized condition with parenchymal, systemic,
and mucocutaneous manifestations.5 The end result may include
dementia, gummata, blindness, paralysis, or death.
Usually yaws and syphilis can only be distinguished by
epidemiological characteristics and clinical manifestations, as
the commonly used antibody tests cannot discriminate one disease
from the other.6
This paper reports on the recalled history of clinical manifesta-
tions of yaws and syphilis by syphilis seroreactive blood donors in
Kumasi, Ghana.ociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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Of the total of 16 016 blood donors tested with a treponemal
Fortress rapid test (Fortress Diagnostics Ltd, Antrim, UK) for T.
pallidum in serum or plasma antibodies (IgG and IgM), 526 (3.3%)
were seroreactive for syphilis. These subjects were further tested
with the rapid plasma reagin test (RPR) (BD Macro-Vue Card test;
BD, Franklin Lakes, New Jersey, USA) to detect potential active
infections. Out of these, 478 cases were conﬁrmed with the Ortho-
Vitros Syphilis TP test as the gold standard. Four hundred and
seventy-one of these conﬁrmed syphilis seroreactive blood donors
were interviewed to determine past or present clinical manifesta-
tions of yaws and syphilis (response rate of 98.5%) (Figure 1).
Subjects were interviewed by a laboratory scientist using a semi-
structured questionnaire in the local dialect for the presence or
absence of current or previous sores or skin ulcers, and skin
lesions/bumps on the face, hands, feet, or genitals. They were also
asked about slow-healing sores and at what age they had
experienced symptoms. Furthermore, they were asked about
any treatment given at the time of these symptoms.
Data were recorded on an Excel spreadsheet and exported into
Stata version 12.0 software (StataCorp, TX, USA) for analysis.
Approval for this study was obtained from the ethics committees of
Kwame Nkrumah University of Science and Technology (KNUST),
Kumasi, Ghana, and the Liverpool School of Tropical Medicine,
Liverpool, UK.
3. Results
The age of conﬁrmed syphilis seroreactive subjects ranged from
17 to 53 years (mean age 31 years, standard deviation 8.6 years).Figure 1. Flowchart of syphilis seroreactive blood donoThere were fewer females (29/471; 6.2%) than males (442/471;
93.8%). Of the 471 respondents, 28 (5.9%) gave a history of skin
lesions and sores (Figure 1). Four (14.3%) individuals out of the
28 donors with a history of skin lesions and sores – all male and
RPR-positive – recalled a diagnosis of syphilis. These four donors
had previously received penicillin treatment during their exposure
to syphilis. Additionally, the four donors with a recall of syphilis
diagnosis reported the appearance of lesions/bumps on the skin
and slow-healing sores, but only one of them had had these
symptoms before the age of 15 years. It could not be clariﬁed
whether this donor had had yaws or syphilis at this young age,
although he had been treated.
4. Discussion
The data presented here suggest that a clinical history of yaws is
not frequent among syphilis-positive blood donors. However,
syphilis symptoms were also not reported frequently. Children
aged below 15 years are the most vulnerable to yaws infection.7
Only a small proportion of conﬁrmed seroreactive donors had any
recall of symptoms or treatment of yaws or syphilis. Thus the
relative contribution of yaws and syphilis to frequent positive tests
in endemic areas remains speculative. The present authors have
previously suggested combined speciﬁc and non-speciﬁc syphilis
testing to identify potential infectious donors.8 The present data
suggest that clinical questioning adds little further information to
this screening algorithm. As a limitation, donors were interviewed
after knowing that they had a positive test for syphilis. This
represents a risk of recall bias, with reporting being inﬂuenced by
the test results. There is furthermore a risk of misclassiﬁcation bias,
as many differential diagnoses exist for both syphilis and yaws.rs interviewed for clinical manifestations of yaws.
F. Sarkodie et al. / International Journal of Infectious Diseases 50 (2016) 72–7474However, despite these limitations, the conclusion that clinical
questioning adds little further information when investigating
syphilis seropositive blood donors in areas where both trepone-
matoses exist seems solid.
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